Pruritus is one of the main features of AD, and Wilson et al.’s257 study revealed that TSLP acts directly on a subset of TRPA1+ sensory neurons to trigger intense itchy behavior, suggesting that KC‐derived TSLP could serve as a therapeutic target for AD‐related pruritus. This evidence concerns the gene TRPA1 and Pruritus.